CEO ACQUITTED OF SECURITIES FRAUD CHARGE

h3-contactInfoContact Information

7 State Street, Charleston, SC 29401
     bart@bartdaniel.com  843.722.2000
     843.722.6254
Monday-Friday | 8:30am-5:00pm View in Google Maps
To read the full article, visit Best Lawyers Website

On April 19, 2017, after a two-week trial, a federal jury unanimously acquitted Revolutions Medical Corporation (RMC) CEO Rondald Wheet on all three counts of securities fraud and false filings with the Securities and Exchange Commission (SEC).

On February 9, 2016, the Federal Grand Jury returned an indictment against CEO Wheet, charging him with conspiracy to commit securities fraud and defrauding the SEC.

Bart Daniel, former United States Attorney for South Carolina, and Michael Sullivan of Ellenoff Grossman & Schole LLP successfully defended Wheet over the course of the two-week federal trial in the Charleston, South Carolina.

Revolutions Medical Corporation is a small South Carolina-based company which develops and distributes innovative products and tools for the medical industry. The company largely focused on creating and perfecting an auto-retractable vacuum safety syringe. Their primary product, the FDA-cleared RevVac™ syringe, was designed to substantially reduce accidental needle stick injuries, using patented vacuum technology to retract the needle directly into the plunger after use, thus preventing its reuse once its safety feature has been activated. RMC’s RevVac™ Auto-Retractable Vacuum Safety Syringe included five international patents and two U.S. patents in order to protect the product and RMC.

The government contended that Wheet fraudulently issued more than 1.2 million shares of Revolutions Medical stock options to 11 unidentified “consultants” through the use of an S-8 form. The S-8 form is a filing with the SEC that is commonly used by startup publically traded companies to register securities that will be offered to its employees via benefit or incentive plans. Simply put, a publically traded company may compensate consultants with stock options in lieu of a cash compensation, provided they perform legitimate services such as legal, accounting or marketing services. The government alleged that these consultants were retained only to raise capital for the fledgling startup. It further alleged no services were actually provided or intended to be provided.

Wheet faced a maximum sentence of 80 years imprisonment. The FBI had investigated the case for two years before the U.S. Attorney presented it to the Grand Jury for Indictment. The co-defendant, the former head of RMC’s Investor Relations, pled guilty and testified against Wheet. Then U.S. Attorney Bill Nettles, in reference to the charges against Wheet, labeled the resources set aside for the investigation as "significant".

Defense attorneys Daniel and Sullivan culled through a decade’s worth of company history, reports, filings, contracts, financial documents and employee backgrounds to prepare for and combat the issues presented by the government.

Daniel focused on each of the consultants and highlighted their individual strengths, knowledge they could offer to Revolutions Medical, and the potential value they were capable and willing to add to the company. These consultants spanned a variety of careers and backgrounds – including professionals in the fields of healthcare, insurance, investing and plastics manufacturing.

Sullivan cross-examined the co-defendant and led CEO Wheet through a day of testimony explaining the company and its SEC fillings.

Both attorneys carefully cross-examined the government’s witnesses. Among those were FBI investigating agents, forensic accountants and securities analysts, as well as past employees of the medical device company, including the co-defendant.

At the close of the trial the federal jury returned a unanimous not guilty verdict for all three counts of securities fraud and false filings with the SEC. It was therefore ordered that Wheet be acquitted, discharged and any bond exonerated.